| pubmed-article:19690548 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C0677850 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C1521996 | lld:lifeskim |
| pubmed-article:19690548 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19690548 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19690548 | pubmed:dateCreated | 2009-9-9 | lld:pubmed |
| pubmed-article:19690548 | pubmed:abstractText | This multicentre randomised phase III trial was designed to determine whether adjuvant chemotherapy with gemcitabine improves the outcomes of patients with resected pancreatic cancer. | lld:pubmed |
| pubmed-article:19690548 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19690548 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19690548 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19690548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19690548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19690548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19690548 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19690548 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19690548 | pubmed:issn | 1532-1827 | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:YamamotoJJ | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:TanakaMM | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:ShimadaMM | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:KosugeTT | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:UenoHH | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:NakasMM | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:MatsuyamaYY | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:MondenMM | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:DoiRR | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:EgawaSS | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:KanemitsuKK | lld:pubmed |
| pubmed-article:19690548 | pubmed:author | pubmed-author:HatoriTT | lld:pubmed |
| pubmed-article:19690548 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19690548 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19690548 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:19690548 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19690548 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19690548 | pubmed:pagination | 908-15 | lld:pubmed |
| pubmed-article:19690548 | pubmed:dateRevised | 2010-9-16 | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:meshHeading | pubmed-meshheading:19690548... | lld:pubmed |
| pubmed-article:19690548 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19690548 | pubmed:articleTitle | A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. | lld:pubmed |
| pubmed-article:19690548 | pubmed:affiliation | Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan. hiueno@ncc.go.jp | lld:pubmed |
| pubmed-article:19690548 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19690548 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19690548 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19690548 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19690548 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19690548 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19690548 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19690548 | lld:pubmed |
